510(k) K031270
K031270 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "ACCESS CEA REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY SYSTEMS". The FDA issued a decision of Substantially Equivalent on May 6, 2003. The device falls under product code DHX (System, Test, Carcinoembryonic Antigen), a Class II device regulated under 21 CFR 866.6010. Beckman Coulter, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 6, 2003
- Date Received
- April 21, 2003
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Carcinoembryonic Antigen
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type